Houston-based gig platform for nurses to launch app next month

help in health care

Nurseify is an on-demand platform that allows nurses and health care organizations to take part in the gig economy. Photo via unsplash.com

Health care executive Benjamin Foster knows that nurses are essential — especially in times of crisis.

In 2017, when Hurricane Harvey struck Houston, he watched as local health care organizations struggled to find nurses who could meet the desperate need at hard-to-reach facilities. And as Regional Chief Human Resources Officer at HCA Houston Healthcare, he had also grown accustomed to the high costs and inefficiencies of traditional medical staffing agencies.

In 2020, in response to the demand for nurses in the pandemic, he decided it was time to act, launching Nurseify in May of that year.

Nurseify is an on-demand platform that allows nurses and health care organizations to take part in the gig economy.With guidance from Rama Walker, Nurseify’s Chief Nursing Officer and Chief Operating Officer with a background in ER administration, the platform uses AI to match nurses with facilities looking to fill short-term assignments.

Nurses are able to set their rates and schedules through the app. Health care facilities can directly vet applicants through their profiles and ratings. The platform also can predict when there might be a higher demand for contract nurses at various facilities based on vacancies and increased patient volume.

“We hope to empower nurses and help individuals take control of their careers by offering transparency and a way to create schedules to better fit their lifestyles,” says Foster, CEO of Nurseify, in a statement. “In this gig-economy, it’s imperative to have an easy and effective way for nurses and healthcare facilities to communicate directly about opportunities, and Nurseify provides a place where they can do just that.”

Additionally, the platform features educational, financial, and support resources for nurse users, as well as options to work with entrepreneurial mentors and wellness coaches with the goal of empowering nurses in what's proven to be a demanding field, especially since the onset of the pandemic.

“As nurse advocates, we prioritize an honest hiring process and nurses’ work-life balance and overall wellbeing,” Walker adds in a statement.

According to the Nurseify team, more than 5,000 nurses have created profiles on the platform at press time; and 60 healthcare facilities have access to Nurseify.

Through the Nuresify mobile app, which launches in May, the company aims to attract more users and health care facilities.

Currently the company is focused on its operations in Texas, Georgia, Florida, and South Carolina, which were pilot states for Nurseify. But the company aims to expand nationally and internationally in the future.

Houston-based acute care startup Kare Technologies launched a similar platform for staffing within the senior living facility and caregiving realms in 2021. Read more about that company here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston edtech company closes oversubscribed $3M seed round

fresh funding

Houston-based edtech company TrueLeap Inc. closed an oversubscribed seed round last month.

The $3.3 million round was led by Joe Swinbank Family Limited Partnership, a venture capital firm based in Houston. Gamper Ventures, another Houston firm, also participated with additional strategic partners.

TrueLeap reports that the funding will support the large-scale rollout of its "edge AI, integrated learning systems and last-mile broadband across underserved communities."

“The last mile is where most digital transformation efforts break down,” Sandip Bordoloi, CEO and president of TrueLeap, said in a news release. “TrueLeap was built to operate where bandwidth is limited, power is unreliable, and institutions need real systems—not pilots. This round allows us to scale infrastructure that actually works on the ground.”

True Leap works to address the digital divide in education through its AI-powered education, workforce systems and digital services that are designed for underserved and low-connectivity communities.

The company has created infrastructure in Africa, India and rural America. Just this week, it announced an agreement with the City of Kinshasa in the Democratic Republic of Congo to deploy a digital twin platform for its public education system that will allow provincial leaders to manage enrollment, staffing, infrastructure and performance with live data.

“What sets TrueLeap apart is their infrastructure mindset,” Joe Swinbank, General Partner at Joe Swinbank Family Limited Partnership, added in the news release. “They are building the physical and digital rails that allow entire ecosystems to function. The convergence of edge compute, connectivity, and services makes this a compelling global infrastructure opportunity.”

TrueLeap was founded by Bordoloi and Sunny Zhang and developed out of Born Global Ventures, a Houston venture studio focused on advancing immigrant-founded technology. It closed an oversubscribed pre-seed in 2024.

Texas space co. takes giant step toward lunar excavator deployment

Out of this world

Lunar exploration and development are currently hampered by the fact that the moon is largely devoid of necessary infrastructure, like spaceports. Such amenities need to be constructed remotely by autonomous vehicles, and making effective devices that can survive the harsh lunar surface long enough to complete construction projects is daunting.

Enter San Antonio-based Astroport Space Technologies. Founded in San Antonio in 2020, the company has become a major part of building plans beyond Earth, via its prototype excavator, and in early February, it completed an important field test of its new lunar excavator.

The new excavator is designed to function with California-based Astrolab's Flexible Logistics and Exploration (FLEX) rover, a highly modular vehicle that will perform a variety of functions on the surface of the moon.

In a recent demo, the Astroport prototype excavator successfully integrated with FLEX and proceeded to dig in a simulated lunar surface. The excavator collected an average of 207 lbs (94kg) of regolith (lunar surface dust) in just 3.5 minutes. It will need that speed to move the estimated 3,723 tons (3,378 tonnes) of regolith needed for a lunar spaceport.

After the successful test, both Astroport and Astrolab expressed confidence that the excavator was ready for deployment. "Leading with this successful excavator demo proves that our technology is no longer theoretical—it is operational," said Sam Ximenes, CEO of Astroport.

"This is the first of many implements in development that will turn Astrolab's FLEX rover into the 'Swiss Army Knife' of lunar construction. To meet the infrastructure needs of the emerging lunar economy, we must build the 'Port' before the 'Ship' arrives. By leveraging the FLEX platform, we are providing the Space Force, NASA, and commercial partners with a 'Shovel-Ready' construction capability to secure the lunar high ground."

"We are excited to provide the mobility backbone for Astroport's groundbreaking construction technology," said Jaret Matthews, CEO of Astrolab, in a release. "Astrolab is dedicated to establishing a viable lunar ecosystem. By combining our FLEX rover's versatility with Astroport's civil engineering expertise, we are delivering the essential capabilities required for a sustainable lunar economy."

---

This article originally appeared on CultureMap.com.

Houston biotech co. raises $11M to advance ALS drug development

drug money

Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment round.

India-based pharmaceuticals company Dr. Reddy’s Laboratories Inc. led the round with a $10 million investment, according to a news release. New York-based investment firm Greenlight Capital, Coya’s largest institutional shareholder, contributed $1.1 million.

The funding was raised through a definitive securities purchase agreement for the purchase and sale of more than 2.5 million shares of Coya's common stock in a private placement at $4.40 per share.

Coya reports that it plans to use the proceeds to scale up manufacturing of low-dose interleukin-2 (IL-2), which is a component of its COYA 302 and will support the commercial readiness of the drug. COYA 302 enhances anti-inflammatory T cell function and suppresses harmful immune activity for treatment of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s disease and Alzheimer’s disease.

The company received FDA acceptance for its investigational new drug application for COYA 302 for treating ALS and FTD this summer. Its ALSTARS Phase 2 clinical trial for ALS treatment launched this fall in the U.S. and Canada and has begun enrolling and dosing patients. Coya CEO Arun Swaminathan said in a letter to investors that the company also plans to advance its clinical programs for the drug for FTD therapy in 2026.

Coya was founded in 2021. The company merged with Nicoya Health Inc. in 2020 and raised $10 million in its series A the same year. It closed its IPO in January 2023 for more than $15 million. Its therapeutics uses innovative work from Houston Methodist's Dr. Stanley H. Appel.

View All Listings